COIN vs INM · P/E 64, rev $2.63B vs rev $4.9M
Coinbase Global Inc (COIN) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. INM currently screens at market cap $5.2M.
Not investment advice. Open the COIN and INM stock pages for the full models.
Not investment advice.